Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%

Disease progression · patients with early stage cervical cancer

The intervention probably leads to lower disease progression (moderate certainty).

1 finding from 1 review

Adjuvant platinum‐based chemotherapy for early stage cervical cancer 2016 · Cochrane Headline outcomes only
HR 0.47 [0.3, 0.74]
2 studies · 297 participants
Moderate

Disease progression · patients with early stage cervical cancer

The intervention showed no clear difference in disease progression (low certainty).

1 finding from 1 review

Adjuvant platinum‐based chemotherapy for early stage cervical cancer 2016 · Cochrane Headline outcomes only
HR 1.34 [0.24, 7.66]
1 study · 71 participants
Low

Disease progression within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)

The intervention probably leads to lower disease progression within 5 years (moderate certainty).

1 finding from 1 review

Radiotherapy and chemoradiation after surgery for early cervical cancer 2012 · Cochrane Headline outcomes only
RR 0.58 [0.37, 0.91]
2 studies · 397 participants
Moderate